Richardson discusses the safety profile of CD19 CAR-T, the debate over B cell targets, and more.
Carrie Richardson, MD
Advertisement
Associate professor of medicine and co-director of the Northwestern Scleroderma Program at Northwestern Medicine
Articles by Carrie Richardson, MD
Carrie Richardson, MD, discusses what early CAR-T trial data mean for reversing damage and redefining remission in systemic sclerosis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement